Literature DB >> 27521790

An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Lidia Sarro1, Nirubol Tosakulwong2, Christopher G Schwarz3, Jonathan Graff-Radford4, Scott A Przybelski2, Timothy G Lesnick2, Samantha M Zuk3, Robert I Reid5, Mekala R Raman3, Bradley F Boeve4, Tanis J Ferman6, David S Knopman4, Giancarlo Comi7, Massimo Filippi8, Melissa E Murray9, Joseph E Parisi10, Dennis W Dickson9, Ronald C Petersen11, Clifford R Jack3, Kejal Kantarci12.   

Abstract

INTRODUCTION: Cerebrovascular lesions on MRI are common in Alzheimer's disease (AD) dementia, but less is known about their frequency and impact on dementia with Lewy bodies (DLB).
METHODS: White-matter hyperintensities (WMHs) and infarcts on MRI were assessed in consecutive DLB (n = 81) and AD dementia (n = 240) patients and compared to age-matched and sex-matched cognitively normal subjects (CN) from a population-based cohort.
RESULTS: DLB had higher WMH volume compared to CN, and WMH volume was higher in the occipital and posterior periventricular regions in DLB compared to AD. Higher WMH volume was associated with history of cardiovascular disease and diabetes but not with clinical disease severity in DLB. Frequency of infarcts in DLB was not different from CN and AD dementia. DISCUSSION: In DLB, WMH volume is higher than AD and CN and appears to be primarily associated with history of vascular disease.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cerebrovascular disease; Dementia with Lewy bodies; Infarcts; MRI; Sex differences; White matter hyperintensities

Mesh:

Year:  2016        PMID: 27521790      PMCID: PMC5303194          DOI: 10.1016/j.jalz.2016.07.003

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  49 in total

1.  Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  Neurodegener Dis       Date:  2010-02-18       Impact factor: 2.977

2.  Pathologies and pathological mechanisms for white matter hyperintensities in depression.

Authors:  Alan J Thomas; Robert Perry; Robert Barber; Raj N Kalaria; John T O'Brien
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

3.  Ecology of the aging human brain.

Authors:  Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine
Journal:  Arch Neurol       Date:  2011-08

4.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.

Authors:  M Yoshita; E Fletcher; D Harvey; M Ortega; O Martinez; D M Mungas; B R Reed; C S DeCarli
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

Review 5.  The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies.

Authors:  S A Vann Jones; J T O'Brien
Journal:  Psychol Med       Date:  2013-03-25       Impact factor: 7.723

6.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

7.  Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women.

Authors:  Limor Raz; M Jayachandran; Nirubol Tosakulwong; Timothy G Lesnick; Samantha M Wille; Matthew C Murphy; Matthew L Senjem; Jeffrey L Gunter; Prashanthi Vemuri; Clifford R Jack; Virginia M Miller; Kejal Kantarci
Journal:  Neurology       Date:  2013-02-13       Impact factor: 9.910

8.  The neuropathology of older persons with and without dementia from community versus clinic cohorts.

Authors:  Julie A Schneider; Neelum T Aggarwal; Lisa Barnes; Patricia Boyle; David A Bennett
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; Michael J Firbank; John T O'Brien
Journal:  Am J Geriatr Psychiatry       Date:  2006-10       Impact factor: 4.105

10.  White matter hyperintensities in mild lewy body dementia.

Authors:  K Oppedal; D Aarsland; M J Firbank; H Sonnesyn; O B Tysnes; J T O'Brien; M K Beyer
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-11-09
View more
  14 in total

1.  White Matter Hyperintensities in the Synucleinopathies: Orthostatic Hypotension, Supine Hypertension, or Both?

Authors:  Horacio Kaufmann; Jose-Alberto Palma
Journal:  Mov Disord Clin Pract       Date:  2020-07-18

Review 2.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

3.  The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Authors:  Jennifer L Whitwell; Peter Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Stephen D Weigand; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2019-03-08       Impact factor: 21.566

4.  The vascular risk factors and vascular neuropathology in subjects with autopsy-confirmed dementia with Lewy bodies.

Authors:  Zhi-Chao Chen; Jinghuan Gan; Yaqi Yang; Qingbo Meng; Jiuyan Han; Yong Ji
Journal:  Int J Geriatr Psychiatry       Date:  2022-03       Impact factor: 3.850

5.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

6.  Metabolic Risk Factors of Alzheimer's Disease, Dementia with Lewy Bodies, and Normal Elderly: A Population-Based Study.

Authors:  Chih-Kuang Cheng; Yu-Chien Tsao; Yuan-Chih Su; Fung-Chang Sung; Hsu-Chih Tai; Woon-Man Kung
Journal:  Behav Neurol       Date:  2018-06-03       Impact factor: 3.342

7.  Microbleeds in dementia with Lewy bodies.

Authors:  Paul C Donaghy; Michael Firbank; Dipayan Mitra; George Petrides; Jim Lloyd; Nicola Barnett; Kirsty Olsen; Alan J Thomas; John T O'Brien
Journal:  J Neurol       Date:  2020-02-04       Impact factor: 4.849

8.  APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia.

Authors:  Saira Saeed Mirza; Usman Saeed; Jo Knight; Joel Ramirez; Donald T Stuss; Julia Keith; Sean M Nestor; Di Yu; Walter Swardfager; Ekaterina Rogaeva; Peter St George Hyslop; Sandra E Black; Mario Masellis
Journal:  Neurology       Date:  2019-10-01       Impact factor: 9.910

9.  Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies.

Authors:  Daniel Ferreira; Zuzana Nedelska; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Christopher G Schwarz; Hugo Botha; Matthew L Senjem; Julie A Fields; David S Knopman; Rodolfo Savica; Tanis J Ferman; Neill R Graff-Radford; Val J Lowe; Clifford R Jack; Ronald C Petersen; Afina W Lemstra; Marleen van de Beek; Frederik Barkhof; Frederic Blanc; Paulo Loureiro de Sousa; Nathalie Philippi; Benjamin Cretin; Catherine Demuynck; Jakub Hort; Ketil Oppedal; Bradley F Boeve; Dag Aarsland; Eric Westman; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2021-05-14       Impact factor: 5.133

10.  Biological subtypes of Alzheimer disease: A systematic review and meta-analysis.

Authors:  Daniel Ferreira; Agneta Nordberg; Eric Westman
Journal:  Neurology       Date:  2020-02-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.